skip to Main Content

Prevail Rapid Weight Loss Program (Tirzepatide) Month 4

Prevail Rapid Weight Loss Program (Tirzepatide) Month 4


What's Included
By purchasing our Tirzepatide Program, you can rest assured that you are working with a qualified weight loss specialist and that your medication will be sourced from a certified pharmacy in the United States.
Doctor Consult
Discuss your treatment plan with one of our licensed doctors
SuppliesAll medications and supplies are included, with no hidden fees
SupportOur well-trained medical staff are ready to answer your questions


Tirzepatide, the active ingredient in Mounjaro, is a GLP-1 drug that is taken once-weekly as an injectable to promote weight loss by regulating blood sugars and reducing hemoglobin A1C levels.



The Prevail Rapid Weight Loss (Tirzepatide) Program includes the following:

  • Tirzepatide Prescription
  • Initial consult with a MyDietDoc physician
  • Initial consult with a MyDietDoc nutrition expert
  • Customized meal plan
  • Monthly health webinars
  • Unlimited texting with our MyDietDoc nutritionist



The number one goal of the Tirzepatide Program is to help promote sustainable weight loss. Losing excess weight can provide many health benefits, such as: 

  • Improved Cardiovascular Health
  • Improved Metabolic Health
  • Restoration of Hormones
  • Reduced Pain
  • Decreased Blood Pressure
  • Decreased Risk for Cardiovascular Disease
  • Better Lung Function
  • Reduced Risk for Stroke or Heart Attack
  • Lower Triglycerides
  • Improved Mobility
  • Less Joint Damage
  • Lower Risk of Erectile Dysfunction
  • Enhanced Libido
  • Higher Self-Esteem
  • Better Sleep



Tirzepatide works similarly to the other drugs in the GLP-1 family, but it contains an extra molecule that may give it a slight edge.

The medication has a dual-action design, mimicking the action of two unique incretin hormones involved in blood sugar control: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This unique dual action makes it the first-in-class medication that acts on both of these receptors.

GIP is a hormone that may complement the effects of GLP-1 receptor agonists. In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure, therefore resulting in weight reductions. When combined with the GLP-1 receptor agonist, GIP usage may have a greater impact on markers of metabolic dysregulation, such as body weight, glucose and lipids.

Incretin hormones are released whenever food is consumed. Among other things, they help promote a feeling of fullness by delaying gastric emptying and activating the satiety centers of the brain. They also boost insulin production in the pancreas, and suppress glucagon production, both of which help normalize blood sugar. All of this happens in a glucose-dependent manner, which means incretin hormones—or their imitators, i.e. GLP-1 and GIP receptor agonists—are unlikely to cause severe hypoglycemia.

What about your natural incretin hormones? Studies have found that overweight or obese individuals may have a reduction in incretin effects, particularly if they have had frequent weight fluctuations due to yo-yo dieting. GLP-1 medication narrows the gap, making it easier to reach your goals and lower your metabolic set point.

B6 is also added in Tirzepatide (10mg/ml). We use the water-soluble compound of Vitamin B6, which is pyridoxine/pyridoxal phosphate. It converts it to its active form in the body, which is the coenzyme pyridoxal 5-phosphate. Having been studied in morning sickness and as an overall antiemetic, especially in fertility, it has been shown to reduce mild to moderate nausea in patients for decades.


*Health consent forms, a doctor consultation, and a doctor approval are all required

*Available in all 50 states.

*Filled with a 3rd party pharmacy

Recommended Add-Ons…

Back To Top